 Mylan Inc raised its bid for Swedish drug maker Meda AB to  billion according to a person familiar with the matter The offer all stock represents a  premium to the share price of just below  Swedish kronor about  when the Financial Times broke news of a Mylan overture earlier this month At  kronor the deal would value Meda at about  billion Early
  